Six African countries – Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia – will be the first on the continent to receive the technology needed to produce their own mRNA vaccines from a scheme headed by the World Health Organization.
The groundbreaking project aims to assist low- and middle-income countries in manufacturing mRNA vaccines at scale and according to international standards, with the aim of ending much of the reliance of African countries on vaccine manufacturers outside the continent.
